Pancreatic ductal adenocarcinoma cell lines have been described to have a low expression of the low-density lipoprotein receptor, the receptor for vesicular stomatitis virus, thus conferring a resistant phenotype to the tumor cells [33]. This evidence concerns the gene VLDLR and pancreatic ductal adenocarcinoma.